12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
The article highlights the performance of 12 health care stocks during Tuesday's after-market session. Nexalin Technology (NXL) saw the highest gain with a 55.8% increase, while Biolase (BIOL) experienced the largest decline, falling by 9.9%.
June 18, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Bone Biologics shares moved upwards by 8.04% to $1.61 during Tuesday's after-market session.
The price increase indicates positive investor sentiment or news related to the company.
CONFIDENCE 70
IMPORTANCE 55
RELEVANCE 100
POSITIVE IMPACT
Dynatronics stock rose 14.74% to $0.4 during Tuesday's after-market session.
The notable price increase suggests positive sentiment or news impacting the stock.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Nexalin Technology shares rose 55.8% to $1.62 during Tuesday's after-market session.
The significant price increase indicates strong investor interest or positive news related to the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
SAB Biotherapeutics stock rose 8.94% to $2.8 during Tuesday's after-market session.
The price increase suggests positive sentiment or news impacting the stock.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Oncology Institute shares moved upwards by 10.8% to $0.45 during Tuesday's after-market session.
The price increase indicates positive investor sentiment or news related to the company.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
Virpax Pharmaceuticals shares increased by 7.17% to $0.61 during Tuesday's after-market session.
The price increase suggests positive sentiment or news impacting the stock.
CONFIDENCE 65
IMPORTANCE 50
RELEVANCE 100
NEGATIVE IMPACT
Biolase stock fell 9.9% to $0.12 during Tuesday's after-market session.
The significant price decrease indicates negative investor sentiment or adverse news related to the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Ensysce Biosciences shares fell 7.82% to $0.52 during Tuesday's after-market session.
The price decrease suggests negative sentiment or news impacting the stock.
CONFIDENCE 65
IMPORTANCE 55
RELEVANCE 100
NEGATIVE IMPACT
Evaxion Biotech stock declined by 9.53% to $2.47 during Tuesday's after-market session.
The notable price decrease suggests negative sentiment or news impacting the stock.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Redhill Biopharma stock decreased by 8.19% to $0.36 during Tuesday's after-market session.
The price decrease suggests negative sentiment or news impacting the stock.
CONFIDENCE 75
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
Sunshine Biopharma stock decreased by 7.86% to $0.36 during Tuesday's after-market session.
The price decrease indicates negative investor sentiment or adverse news related to the company.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Soligenix stock decreased by 8.5% to $3.88 during Tuesday's after-market session.
The price decrease indicates negative investor sentiment or adverse news related to the company.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100